In chronic urticaria, also known as chronic hives, there is a high unmet need for new treatments aimed at patients resistant to antihistamines. Four major clinical trial readouts for hives expected in 2023 could shed light on whether a slate of antibiotics in development will help fill this void.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,